[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/main/docs/Technology/index.md) >> Individual ID:PBN__Technology_238 

# __Anti-inflammatory drugs__

## Category to which it belongs

* [Creating a resilient and adaptable environment through technology, cooperation, contact tracing, natural elements, and proper measures.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_169.md)

## Closest similar item

* [Anti-bacterial](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3260.md)
* [Anti-malaria drugs](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_237.md)
* [Antimalarial](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3291.md)
* [Antimicrobial coating](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_236.md)
* [Antimicrobial coatings](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3292.md)
* [Antimicrobial materials](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3293.md)
* [Antiviral](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_787.md)
* [Antiviral drugs](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2830.md)
* [Antivirals](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2870.md)
* [Medications](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_827.md)

## Risks linked to this technology

* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1139.md)

## This Technology enables the following mitigations

* [Drug therapies](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3314.md)

## This technology is mentioned by

* [An environmental and health perspective for COVID-19 outbreak: Meteorology and air quality influence, sewage epidemiology indicator, hospitals disinfection, drug therapies and recommendations](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_270.md)

